Global POEMS Syndrome Market 2025 by Company, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global POEMS Syndrome market size was valued at US$ 1113 million in 2024 and is forecast to a readjusted size of USD 1609 million by 2031 with a CAGR of 5.5% during review period.
POEMS syndrome is a rare blood disorder that damages your nerves and affects other parts of your body. POEMS stands for these signs and symptoms: Polyneuropathy. Numbness, tingling and weakness in your legs — and over time, maybe in your hands — and difficulty breathing.
The global POEMS syndrome market refers to the market for diagnosing and treating POEMS syndrome, a rare multisystem disorder. POEMS syndrome is a rare plasma cell disorder that affects multiple systems, including the peripheral nerves, bone marrow, and blood vessels. The acronym “POEMS” stands for polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes.
The market for POEMS syndrome is driven by several factors, including the increasing prevalence of the condition, advancements in diagnostic techniques, and the development of targeted treatment options. POEMS syndrome is usually diagnosed through a combination of clinical symptoms, specialized laboratory tests, imaging studies, and biopsy of affected tissues. Accurate and early diagnosis is crucial to initiate appropriate treatment and manage complications.
Treatment options for POEMS syndrome depend on individual patient characteristics, disease severity, and involvement of different systems. The main treatment approach is to target the underlying plasma cell disorder. High-dose chemotherapy with autologous stem cell transplantation (ASCT) is commonly used to achieve disease control and improve outcomes. Immunomodulatory drugs, corticosteroids, and radiation therapy may also be used alone or in combination.
Geographically, North America and Europe are major contributors to the global POEMS syndrome market due to well-established healthcare systems, advanced treatment facilities, and a higher prevalence of the condition. The market in the Asia-Pacific region is also expanding due to improving healthcare infrastructure, increased awareness, and rising cases of POEMS syndrome. There may be geographical variations in disease presentation, management, and access to treatment options.
Key players in the global POEMS syndrome market include pharmaceutical companies, research institutions, and healthcare providers specialized in hematologic malignancies. These players focus on developing novel treatment options, conducting clinical trials, and collaborating with patients and patient advocacy groups to improve patient outcomes and quality of life.
Challenges in the market include the rarity of the condition, delayed diagnosis due to variable and non-specific symptoms, and limited understanding of the disease mechanisms. Research efforts are ongoing to better understand the pathogenesis of POEMS syndrome and explore new therapeutic targets. Early detection, multidisciplinary management, and ongoing medical care are crucial for improving outcomes in POEMS syndrome patients.
In summary, the global POEMS syndrome market is driven by factors such as the increasing prevalence of the condition, advancements in diagnostic techniques, and the development of targeted treatment options. North America and Europe currently lead the market, but the Asia-Pacific region is also growing. Key players in the market continue to focus on research and development to improve patient outcomes and overall quality of life.
This report is a detailed and comprehensive analysis for global POEMS Syndrome market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global POEMS Syndrome market size and forecasts, in consumption value ($ Million), 2020-2031
Global POEMS Syndrome market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global POEMS Syndrome market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global POEMS Syndrome market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for POEMS Syndrome
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global POEMS Syndrome market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Bristol Myers Squibb, Baxter International, Genentech, Takeda Pharmaceuticals U.S.A., Oncopeptides, Acrotech Biopharma LLC, LGM Pharma, LLC, Jubilant Cadista Pharmaceuticals Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
POEMS Syndrome market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chemotherapy
Radiation Therapy
Physical Therapy
Others
Market segment by Application
Hospitals
Specialty Clinics
Outpatient Surgery Center
Others
Market segment by players, this report covers
Pfizer
Bristol Myers Squibb
Baxter International
Genentech
Takeda Pharmaceuticals U.S.A.
Oncopeptides
Acrotech Biopharma LLC
LGM Pharma, LLC
Jubilant Cadista Pharmaceuticals Inc
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe POEMS Syndrome product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of POEMS Syndrome, with revenue, gross margin, and global market share of POEMS Syndrome from 2020 to 2025.
Chapter 3, the POEMS Syndrome competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and POEMS Syndrome market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of POEMS Syndrome.
Chapter 13, to describe POEMS Syndrome research findings and conclusion.
POEMS syndrome is a rare blood disorder that damages your nerves and affects other parts of your body. POEMS stands for these signs and symptoms: Polyneuropathy. Numbness, tingling and weakness in your legs — and over time, maybe in your hands — and difficulty breathing.
The global POEMS syndrome market refers to the market for diagnosing and treating POEMS syndrome, a rare multisystem disorder. POEMS syndrome is a rare plasma cell disorder that affects multiple systems, including the peripheral nerves, bone marrow, and blood vessels. The acronym “POEMS” stands for polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes.
The market for POEMS syndrome is driven by several factors, including the increasing prevalence of the condition, advancements in diagnostic techniques, and the development of targeted treatment options. POEMS syndrome is usually diagnosed through a combination of clinical symptoms, specialized laboratory tests, imaging studies, and biopsy of affected tissues. Accurate and early diagnosis is crucial to initiate appropriate treatment and manage complications.
Treatment options for POEMS syndrome depend on individual patient characteristics, disease severity, and involvement of different systems. The main treatment approach is to target the underlying plasma cell disorder. High-dose chemotherapy with autologous stem cell transplantation (ASCT) is commonly used to achieve disease control and improve outcomes. Immunomodulatory drugs, corticosteroids, and radiation therapy may also be used alone or in combination.
Geographically, North America and Europe are major contributors to the global POEMS syndrome market due to well-established healthcare systems, advanced treatment facilities, and a higher prevalence of the condition. The market in the Asia-Pacific region is also expanding due to improving healthcare infrastructure, increased awareness, and rising cases of POEMS syndrome. There may be geographical variations in disease presentation, management, and access to treatment options.
Key players in the global POEMS syndrome market include pharmaceutical companies, research institutions, and healthcare providers specialized in hematologic malignancies. These players focus on developing novel treatment options, conducting clinical trials, and collaborating with patients and patient advocacy groups to improve patient outcomes and quality of life.
Challenges in the market include the rarity of the condition, delayed diagnosis due to variable and non-specific symptoms, and limited understanding of the disease mechanisms. Research efforts are ongoing to better understand the pathogenesis of POEMS syndrome and explore new therapeutic targets. Early detection, multidisciplinary management, and ongoing medical care are crucial for improving outcomes in POEMS syndrome patients.
In summary, the global POEMS syndrome market is driven by factors such as the increasing prevalence of the condition, advancements in diagnostic techniques, and the development of targeted treatment options. North America and Europe currently lead the market, but the Asia-Pacific region is also growing. Key players in the market continue to focus on research and development to improve patient outcomes and overall quality of life.
This report is a detailed and comprehensive analysis for global POEMS Syndrome market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global POEMS Syndrome market size and forecasts, in consumption value ($ Million), 2020-2031
Global POEMS Syndrome market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global POEMS Syndrome market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global POEMS Syndrome market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for POEMS Syndrome
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global POEMS Syndrome market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Bristol Myers Squibb, Baxter International, Genentech, Takeda Pharmaceuticals U.S.A., Oncopeptides, Acrotech Biopharma LLC, LGM Pharma, LLC, Jubilant Cadista Pharmaceuticals Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
POEMS Syndrome market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chemotherapy
Radiation Therapy
Physical Therapy
Others
Market segment by Application
Hospitals
Specialty Clinics
Outpatient Surgery Center
Others
Market segment by players, this report covers
Pfizer
Bristol Myers Squibb
Baxter International
Genentech
Takeda Pharmaceuticals U.S.A.
Oncopeptides
Acrotech Biopharma LLC
LGM Pharma, LLC
Jubilant Cadista Pharmaceuticals Inc
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe POEMS Syndrome product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of POEMS Syndrome, with revenue, gross margin, and global market share of POEMS Syndrome from 2020 to 2025.
Chapter 3, the POEMS Syndrome competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and POEMS Syndrome market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of POEMS Syndrome.
Chapter 13, to describe POEMS Syndrome research findings and conclusion.
Table of Contents
81 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
- 10 Middle East & Africa
- 11 Market Dynamics
- 12 Industry Chain Analysis
- 13 Research Findings and Conclusion
- 14 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
